Back to search
FDAFDA · Food and drugs·Recall number D-0173-2019

Prostaglandin E1 150 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1623-05

Published November 7, 2018 · Recall initiated: September 10, 2018

Summary

FDA records drug Class II recall D-0173-2019, published November 7, 2018 and initiated September 10, 2018. Recalling firm: Pharm D Solutions, LLC; Status: Terminated; Reported quantity: 193 milliliters; Lot: Lot: 04262018:18 Discard by: 10/22/2018; 03292018:66 Discard by: 9/24/2018; 05312018:19 Discard by: 11/27/2018; 07022018:55 Discard by: 12/29/2018; 06122018:51 Discard by: 12/9/2018; 07242018:71 Discard by: 1/20/2019; 08302018:90 Discard by: 2/23/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharm D Solutions, LLC
Distributor
Nationwide
Lot
Lot: 04262018:18 Discard by: 10/22/2018; 03292018:66 Discard by: 9/24/2018; 05312018:19 Discard by: 11/27/2018; 07022018:55 Discard by: 12/29/2018; 06122018:51 Discard by: 12/9/2018; 07242018:71 Discard by: 1/20/2019; 08302018:90 Discard by: 2/23/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Prostaglandin E1 150 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1623-05 recalled?

Yes. FDA published recall D-0173-2019 on November 7, 2018. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Press Release